NCT01969461

Brief Summary

Alcohol use among persons with HIV exacerbates health problems and accelerates HIV disease progression. Antiretroviral therapy (ART) is the single most important treatment for people living with HIV. However, ART adherence is suboptimal among adolescents and young adults living with HIV, the age group with the fastest growing rates of HIV infection, and great risk of engaging in risky behaviors such as alcohol use. The proposed study will compare the effectiveness of home-based versus clinic-based "Healthy Choices", a brief, 4- session intervention using Motivational Enhancement Therapy (MET) to address alcohol use, medication adherence, and health outcomes in youth living with HIV (YLH) using a repeated measures design. Unlike previous trials, Healthy Choices will be tested in a "real world" clinical setting and be delivered by community health workers (CHW: already members of the HIV care team). The study population will consist of YLH, ages 16-24, who are current patients at 5 ATN sites. Site staff will recruit potential participants. Youth will be randomized to receive Healthy Choices, either clinic-based or home-based delivered by the same CHW in both conditions. Outcomes are measured at baseline, 4-, 7-, and 13-months. Data collection for biological measures will be through medical record extraction, and self-reported measures will occur using a brief Web-based CASI (computer-administered self-interviewing) survey on an iPad. All intervention sessions will be audio-recorded for MITI fidelity coding, and investigators will support local supervisors during the active intervention phase. We will conduct qualitative interviews with CHWs, supervisors and organization leaders at the end of the trial to obtain information about barriers and facilitators of implementation. Thus, the proposed trial will allow us to use a Type 1 Effectiveness-implementation hybrid design to pilot a sustainable model of MI implementation in real-world youth care settings towards the goals of 1) examining the effectiveness, cost-effectiveness, and scalability of an efficacious behavioral intervention when delivered by CHWs in real-world adolescent HIV care settings; 2) gathering information about who responds under what contexts; and 3) increasing our understanding of the barriers and facilitators for future implementation. The primary hypothesis is that YLH receiving home-based MET will have greater improvements in alcohol use and viral load than YLH receiving clinic-based MET.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P50-P75 for not_applicable hiv

Timeline
Completed

Started Jul 2014

Longer than P75 for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 17, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 25, 2013

Completed
8 months until next milestone

Study Start

First participant enrolled

July 1, 2014

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

January 9, 2017

Status Verified

January 1, 2017

Enrollment Period

4.4 years

First QC Date

October 17, 2013

Last Update Submit

January 6, 2017

Conditions

Keywords

HIV positiveAdolescentsAdolescent Trials NetworkComparative Effectiveness TrialImplementationAdherence InterventionAlcohol Intervention

Outcome Measures

Primary Outcomes (2)

  • Change in Alcohol Use from Baseline to 9 months post intervention

    We will use multiple methods of assessing use including calendar-based interview, biomarker, and self-report questionnaire.

    Baseline, 4-, 7-, and 13-months

  • Change in Viral Load from Baseline to 9 months post intervention

    Viral load will be extracted from medical records, though we have budgeted to collect a percentage of viral loads for youth who drop out of care or transfer to a care setting where records are not available.

    Baseline, 4-, 7-, and 13-months

Secondary Outcomes (3)

  • Change in Medication Adherence from Baseline to 9 months post intervention

    Baseline, 4-, 7-, and 13-months

  • Change in Sexual Risk from Baseline to 9 months post intervention

    Baseline, 4-, 7-, and 13-months

  • Change in Other Substance Use (not alcohol use) from Baseline to 9 months post intervention

    Baseline, 4-, 7-, and 13-months

Other Outcomes (2)

  • Barriers and Facilitators of the MI Implementation Process

    4 months post baseline

  • Barriers and Facilitators of the MI Implementation Process

    13 months post Baseline

Study Arms (2)

Healthy Choices: MET CHW Clinic

EXPERIMENTAL

The 4-session Motivational Enhancement Therapy (MET) intervention will address alcohol use and HIV medication (ART) adherence. Sessions will be delivered in the CLINIC by a CHW (outreach worker, etc) already providing services in the clinic. The intervention is based on Motivational Interviewing (MI) techniques, building motivation for change by eliciting and reinforcing change talk.

Behavioral: Motivational Enhancement Therapy (MET)

Healthy Choices: MET CHW Home

ACTIVE COMPARATOR

The 4-session Motivational Enhancement Therapy (MET) intervention will address alcohol use and HIV medication (ART) adherence. Sessions will be delivered in the HOME by a CHW (outreach worker, etc) already providing services in the clinic. The intervention is based on Motivational Interviewing (MI) techniques, building motivation for change by eliciting and reinforcing change talk.

Behavioral: Motivational Enhancement Therapy (MET)

Interventions

The 4-session MET intervention will address alcohol use and HIV medication (ART) adherence. Sessions will be delivered in the clinic or the home by a CHW (outreach worker, etc) already providing services in the clinic. In sessions 1 and 2 (each behavior will get its own session), CHW will elicit the client's view of the problem using MI techniques, building motivation for change by eliciting and reinforcing change talk. The CHW will deliver feedback and discuss the consideration of a behavior change plan option, and the client sets the change plan goal and consolidates commitment. In the last two sessions, the CHW will review the change plan, continue to elicit and reinforce change talk, problem-solve barriers, consolidate commitment, and consider strategies to maintain behavior change.

Also known as: Motivational Interviewing
Healthy Choices: MET CHW ClinicHealthy Choices: MET CHW Home

Eligibility Criteria

Age16 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • HIV-infected
  • Ability to speak and understand English
  • Prescribed antiretroviral therapy
  • Detectable viral load in the last month

You may not qualify if:

  • Not fluent in English
  • History of sever learning disability, mental retardation, major psychiatric disorders (e.g., schizophrenia, bipolar disorder, major depression with psychotic features, etc).
  • Participation in another adherence intervention trial
  • On ART due to pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Adolescent Trials Network (ATN) Sites

Birmingham, Alabama, 35215, United States

RECRUITING

Related Publications (1)

  • Naar S, Robles G, MacDonell KK, Dinaj-Koci V, Simpson KN, Lam P, Parsons JT, Sizemore KM, Starks TJ. Comparative Effectiveness of Community-Based vs Clinic-Based Healthy Choices Motivational Intervention to Improve Health Behaviors Among Youth Living With HIV: A Randomized Clinical Trial. JAMA Netw Open. 2020 Aug 3;3(8):e2014650. doi: 10.1001/jamanetworkopen.2020.14650.

MeSH Terms

Conditions

HIV SeropositivityAdherence Interventions

Interventions

Motivational Interviewing

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesMedication AdherencePatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Directive CounselingCounselingMental Health ServicesBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Sylvie Naar-King, PhD

    Wayne State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sylvie Naar-King, PhD

CONTACT

Phebe Lam, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 17, 2013

First Posted

October 25, 2013

Study Start

July 1, 2014

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

January 9, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share

Locations